Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells

Bone destruction induced by the metastasis of breast cancer cells is a frequent complication that is caused by the interaction between cancer cells and bone cells. Receptor activator of nuclear factor kappa-B ligand (RANKL) and the endogenous soluble RANKL inhibitor, osteoprotegerin (OPG), directly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer Prev
Main Authors: Lee, Sun Kyoung, Park, Kwang-Kyun, Kim, Ki Rim, Kim, Hyun-Jeong, Chung, Won-Yoon
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Cancer Prevention 2015
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4699756/
https://ncbi.nlm.nih.gov/pubmed/26734591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15430/JCP.2015.20.4.281
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados